High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.
Fujita H, Ohuchida K, Mizumoto K, Itaba S, Ito T, Nakata K, Yu J, Kayashima T, Hayashi A, Souzaki R, Tajiri T, Onimaru M, Manabe T, Ohtsuka T, Tanaka M.
Fujita H, et al. Among authors: souzaki r.
Int J Oncol. 2011 Mar;38(3):629-41. doi: 10.3892/ijo.2011.908. Epub 2011 Jan 17.
Int J Oncol. 2011.
PMID: 21243324